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RBM45 associates with nuclear stress
bodies and forms nuclear inclusions during
chronic cellular stress and in
neurodegenerative diseases
Mahlon Collins1,2,3, Yang Li1,4 and Robert Bowser1*
Abstract
The RNA binding protein (RBP) RBM45 forms nuclear and cytoplasmic inclusions in neurons and glia in amyotrophic
lateral sclerosis (ALS), frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP), and Alzheimer’s
disease (AD). The normal functions of RBM45 are poorly understood, as are the mechanisms by which it forms
inclusions in disease. To better understand the normal and pathological functions of RBM45, we evaluated whether
the protein functions via association with several membraneless organelles and whether such an association could
promote the formation of nuclear RBM45 inclusions. Under basal conditions, RBM45 is diffusely distributed
throughout the nucleus and does not localize to membraneless organelles, including nuclear speckles, Cajal bodies,
or nuclear gems. During cellular stress, however, nuclear RBM45 undergoes a reversible, RNA-binding dependent
incorporation into nuclear stress bodies (NSBs). Chronic stress leads to the persistent association of RBM45 with
NSBs and the irreversible accumulation of nuclear RBM45 inclusions. We also quantified the cell type- and disease-
specific patterns of RBM45 pathology in ALS, FTLD-TDP, and AD. RBM45 nuclear and cytoplasmic inclusions are
found in both neurons and glia in ALS, FTLD-TDP, and AD but are absent in non-neurologic disease controls. Across
neurodegenerative diseases, RBM45 nuclear inclusion pathology occurs more frequently than cytoplasmic RBM45
inclusion pathology and exhibits cell type-specific variation. Collectively, our results define new stress-associated
functions of RBM45, a mechanism for nuclear RBM45 inclusion formation, a role for NSBs in the pathogenesis of
ALS, FTLD-TDP, and AD, and further underscore the importance of protein self-association to both the normal and
pathological functions of RBPs in these diseases.
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Introduction
RBM45 is a developmentally regulated RNA binding
protein (RBP) that forms nuclear and cytoplasmic inclu-
sions in neurons and glia in amyotrophic lateral sclerosis
(ALS), frontotemporal lobar degeneration with TDP-43
proteinopathy (FTLD-TDP), and Alzheimer’s disease
(AD) [1, 2]. Nuclear and cytoplasmic RBM45 inclusions
have distinct compositions and morphologies. Cytoplas-
mic RBM45 inclusions contain TDP-43 and ubiquitin
and exhibit a skein-like or globular morphology. In con-
trast, nuclear RBM45 inclusions are punctate in appear-
ance and are negative for other disease-linked RBPs,
including TDP-43 and FUS [1]. Aside from these unique
properties, however, little is known about nuclear
RBM45 inclusions. In particular, the mechanisms leading
to their formation, their impact on cellular viability, and
the cell-type specific patterns of nuclear RBM45 path-
ology across diseases remain unknown.
To better understand RBM45 inclusion formation, we
and others have begun to characterize the normal func-
tions of RBM45. The first efforts to this end focused on
identifying functional domains in the RBM45 protein. By
virtue of a bipartite nuclear localization sequence (NLS),
RBM45 is a predominantly nuclear protein under basal
conditions [3–5]. Mutation of the RBM45 NLS leads to
cytoplasmic sequestration of the protein, with attendant
incorporation into cytoplasmic stress granules (SGs) [4,
5]. RBM45 also contains 3 RNA recognition motifs
(RRMs) that govern its binding to RNA sequences, with
a GC-rich sequence preference [4–6]. Finally, RBM45
contains a novel “homo-oligomer assembly” (HOA) do-
main, an internal intrinsically disordered region that me-
diates the ability of RBM45 to self-associate and interact
with other RBPs (including TDP-43 and FUS) [4, 6, 7].
Our studies of the HOA domain demonstrated that cel-
lular RBM45 protein frequently exists in a high-
molecular weight, oligomeric conformation, presumably
as part of its normal function(s) [4, 7]. This type of RBP
self-association or oligomerization is often required for
or accompanies RBP incorporation into membraneless
organelles such as SGs, P-bodies, nucleoli, paraspeckles,
and Cajal bodies [8, 9]. We also used immunoprecipita-
tion coupled to mass-spectrometry (IP-MS) experiments
to identify RBM45-interacting proteins and infer that
RBM45 regulates mRNA splicing and spliceosome func-
tion in the nucleus [3]. Collectively, our observations
that RBM45 self-associates and regulates mRNA pro-
cessing suggest that the protein may be a component of
one or more membraneless nuclear organelles that regu-
late mRNA splicing and processing, such as nuclear
speckles or Cajal bodies.
While self-association of RBPs is critical for membra-
neless organelle formation and function, this process
also contributes to inclusion formation in diseases such
as ALS and FTLD [8, 10–13]. A well-studied example of
this phenomenon is the RBP aggregation and inclusions
that result from RBP incorporation and entrapment in
cytoplasmic SGs [14, 15]. SGs are cytoplasmic protein-
mRNA complexes that form in response to cellular
stress [16, 17]. They protect mRNAs from a harmful cel-
lular environment and stall their translation, thus con-
serving energy and prioritizing translation of stress
response-associated proteins (reviewed in [16, 17]).
TDP-43 and FUS are components of SGs and chronic
confinement of these RBPs in SGs results in the forma-
tion of insoluble inclusions containing these proteins in
a variety of model systems [14, 18–21]. Likewise, SG
marker proteins are found in TDP-43 and FUS-positive
neuronal cytoplasmic inclusions in ALS and FTLD pa-
tients, suggesting that SGs are capable of seeding inclu-
sion formation [19, 22]. The presence of low complexity
and intrinsically disordered domains in these and other
SG-associated RBPs facilitates aggregation and can lead
to the formation of several forms of amyloid or amyloid-
like structures, including amyloidogenic oligomers and
fibrils [23–26]. This pathological “maturation” of RBP
assemblies into insoluble aggregates and inclusions
removes RBPs from their normal cellular milieu, leading
to loss of normal RBP function(s) [27–30]. We propose
that an analogous process occurring in the nucleus con-
tributes to both the normal functions of RBM45 and the
formation of the nuclear RBM45 inclusions seen in ALS,
FTLD-TDP, and AD.
To test this hypothesis, we explored the association of
RBM45 with a variety of membraneless nuclear organ-
elles, including nuclear speckles, Cajal bodies, nuclear
gems, and nuclear stress bodies (NSBs). We found that
RBM45 is recruited to NSBs following exposure to a di-
verse array of cellular stressors. This association is
dependent on the protein’s NLS and ability to bind
RNA. The persistent association of RBM45 with NSBs is
sufficient to promote its aggregation into insoluble in-
clusions and, unlike NSBs, these complexes do not disas-
semble, but instead increase in size and number over
time. Collectively, our results (1) identify novel functions
of RBM45; (2) define a new mechanism by which the
stress-associated functions of RBPs contribute to their
aggregation and inclusion formation; and (3) provide
quantitative measures of the cell type and disease-
specific patterns of RBM45 pathology that occur in ALS,
FTLD, and AD.
Methods
Cell culture, transfection, and nuclear stress body
induction
HEK293 cells or FreeStyle 293F cells (Invitrogen, Wal-
tham, MA, USA; RRID:CVCL_0045 and RRID:CVCL_
D603, respectively) were cultured in DMEM medium
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with 10% FBS and 1% Pen-Strep at 37 °C with 5% CO2.
Mycoplasma detection was performed using DAPI stain-
ing and the Lookout Mycoplasma PCR detection kit
(Sigma-Aldrich, St. Louis, MA, USA). The Lipofectamine
3000 reagent (Invitrogen) was used to transfect cells ac-
cording to the manufacturer’s protocol and transfected
cells were harvested 48 or 72 h post-transfection. Tet-
inducible EGFP-RBM45 stable cell lines (see below) were
maintained in the presence of 50 μg/ml Zeocin (Invivo-
Gen, San Diego, CA, USA). EGFP-RBM45 expression
was induced by adding 1 μg/ml doxycycline hyclate
(Sigma-Aldrich) for 16 h before live-cell imaging.
To induce nuclear stress body (NSB) formation, we
used a variety of previously described stressor protocols.
Heat shock was performed by incubating the cells in a
42 °C environment for various durations (ranging from
0.5 to 2 h, as indicated in the text/figures) followed by
various recovery times, ranging from 1 to 24 h, as indi-
cated [31, 32]. The following reagents were added to cul-
ture medium at the indicated concentrations to induce
NSB formation, as previously described: 5–30 μM
CDSO4 (2–24 h) [32, 33], 200–400 μM H2O2 (2–24 h)
[32, 34], 0.1–1 mM sodium arsenite (0.25–24 h) [35], or
0.5–20 μM mitoxantrone (MTX; 2–24 h) [36].
Plasmid construction
For expression of WT and domain deletion RBM45 con-
structs, a plasmid containing RBM45, cGST-hRBM45
(HsCD00356971), was obtained from the DNASU Plas-
mid Repository at Arizona State University, Tempe, AZ,
USA. The RBM45 cDNA was amplified by PCR using
Phusion High-Fidelity DNA Polymerase (NEB) and sub-
cloned into the pcDNA3 vector (Invitrogen). A 3xFLAG
tag (DYKDHDGDYKDHDIDYKDDDDK) or 2xHA tag
(DYPYDVPDYAGGAAYPYDVPDYA) was appended to
the N-terminus of RBM45 to generate the 3xFLAG- or
2xHA-tagged constructs, respectively. In previous exper-
iments, we found that appending tags to the C-terminus
of the protein alters its subcellular localization, presum-
ably by interfering with the function of the C-terminal
nuclear localization sequence (amino acids 454–472 of
474). Thus, all RBM45 tags were appended to the pro-
tein’s N-terminus. Domain deletions and mutations were
introduced by site-directed mutagenesis using overlap
extension PCR [37]. Sequences of RBM45 domain dele-
tion and non-functional NLS mutant constructs were as
in Li et al. [4]. For live-cell imaging of RBM45 dynamics
during conditions of cellular stress, a Tet-inducible
EGFP-RBM45 construct was generated by inserting the
EGFP-RBM45 (N-terminal EGFP fusion) into the
pcDNA4/TO vector (Invitrogen). The sequences of all
constructs were confirmed by Sanger DNA sequencing
and the sizes of the expressed proteins confirmed by
Western blot.
Inducible EGFP-RBM45 cell line
Creation of the Tet-on parental stable cell line
HEK293 cells were transfected with pcDNA6/TR (Invi-
trogen) to express the Tet repressor and selected with
10 μg/ml Blasticidin (InvivoGen, San Diego, CA, USA).
Multiple stable clones were isolated, propagated, trans-
fected with pcDNA4/TO/lacZ (Invitrogen), and induced
with 10 μg/ml doxycycline hyclate (Sigma-Aldrich) for
the expression of ß-galactosidase. The ß-Gal assay was
performed to screen for clones with the highest expres-
sion of the Tet repressor. A Tet-on parental clone with a
combination of the lowest ß-galactosidase levels without
doxycycline induction and highest expression of ß-galac-
tosidase in the presence of doxycycline was then se-
lected. This line was maintained with 5 μg/ml
Blasticidin.
Creation of inducible EGFP-RBM45 cell line
pcDNA4/TO-EGFP-RBM45 was transfected into the
Tet-on parental stable cell line above and EGFP-positive
stable cell lines were selected in the presence of 100 μg/
ml Zeocin.
CRISPR-Cas9 modified FLAG-RBM45 cell line
A 3xFLAG tag was appended to the N-terminus of the
endogenous RBM45 genomic locus in HEK293 cells
using the CRISPR-Cas9 method described by Ran et al.
[38] with some modifications.
sgRNA preparation
Five sgRNA sequences near the N-terminus of the
RBM45 genomic locus were selected using the CRISPR
Design Tool (http://crispr.mit.edu) [38]. Oligos encoding
the five sgRNAs were individually cloned into the
pSpCas9(BB)-2A-Puro (PX459) V2.0 vector (RRID:
Addgene_62988) and transfected into HEK293 cells.
Cells were selected in the presence of 5 μg/ml puro-
mycin (InvivoGen) for 48 h before functional validation
of sgRNAs. The cleavage efficiency of each sgRNA
was evaluated by the TIDE (Tracking of Indels by DE-
composition) assay [39]. Briefly, genomic DNA from
puromycin selected cells and wild-type HEK293 cells
was extracted (Promega Wizard Genomic DNA Purifica-
tion Kit #A1120; Promega, Madison, WI, USA) for PCR
amplification of a 535 bp region flanking the sgRNA
cleavage site. The PCR DNAs were gel purified (Pro-
mega Wizard SV Gel and PCR Clean-up System
#A9282) and 30 ng of each PCR DNA was Sanger se-
quenced. The sequencing result for each sgRNA was
aligned to the wild-type control by TIDE software
(https://tide.nki.nl/) and the resulting traces were used
to calculate cleavage efficiencies [39]. The two sgRNAs
with the highest cleavage efficiency (both 85%) were
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chosen for co-transfection with a homology-directed re-
pair (HDR) template for CRISPR-Cas9 genome editing.
Generation of CRISPR-Cas9 modified FLAG-RBM45 HEK293
cell line
A 200 nt ssODN ultramer (IDT) was used as a
homology-directed repair (HDR) template for CRISPR-
Cas9 editing of the endogenous RBM45 locus. Co-
transfection of 500 ng sgRNA plasmid and 1 μl of 10 μM
ssODN template into 2 × 105 HEK293 cells was per-
formed using nucleofection on the 4D-Nucleofector sys-
tem (LONZA, Basel, Switzerland), as in [38]. The
transfected cells were enriched by selection with 1 μg/ml
puromycin for 48 h. Clonal cell lines were isolated by
serial dilution and expanded for 3 weeks. Genomic DNA
from cell lines growing on 96-well plates was extracted
by 25 μl QuickExtract DNA extraction solution (Epi-
centre #QE09050, Madison, WI, USA), further diluted to
200 μl with H2O. CRISPR-Cas9 genome editing was
assessed by using genomic DNA from these samples for
PCR amplification of the RBM45 genomic locus using a
FLAG-specific forward primer and an RBM45 reverse
primer flanking a 480 bp region. The 480 bp PCR DNAs
were then Sanger sequenced to verify the correct inser-
tion of the 3xFLAG into the desired genomic locus.
Real-time PCR was used to measure RBM45 mRNA
levels in wild-type and FLAG-RBM45 expressing cell
lines. We then used immunostaining to assess the nu-
clear morphology, subcellular localization, and RBM45
protein levels in CRISPR modified FLAG-RBM45 and
wild-type HEK293 cells.
Primers used for TIDE assay
PCR forward primer: 5′-GGACTCCTCTTTCT
CCCGGAAGCGG
PCR reverse primer: 5′-GCTGCCGGGAACGGATGT
TCCACTC
Sequencing forward primer: 5′-ACTCCTCTTTCTCC
CGGAAGCGGAG
Sequencing reverse primer: 5′-TGCCGGGAACGGAT
GTTCCACTCCT













Primers to PCR amplify CRISPR modified endogenous FLAG-
RBM45
FLAG-specific forward primer: 5′-TCGGGTGGAG
CACCATGGACTACAAAG
RBM45 reverse primer: 5′-GCTGCCGGGAACGG
ATGTTCCACTC
siRNA knockdown of RBM45 and SatIII
To assess the effects of knockdown of endogenous
RBM45 or SatIII expression on NSB formation, siRNAs
targeting each transcript were designed based on previ-
ous studies [40, 41] and transfected into HEK293 cells.
Two siRNAs targeting RBM45 and one siRNA targeting
SatIII were used, along with a scrambled siRNA as a
negative control. For all siRNA knockdown studies, 40%
confluent HEK293 cells growing on 24- or 96-well plates
were transfected with 15 pmol or 3 pmol of siRNA, re-
spectively, using the Lipofectamine 3000 reagent (Invi-
trogen) according to the manufacturer’s instructions.
Cells were immunostained or assayed for cellular viabil-
ity 48 h post-transfection. siRNAs (Dharmacon, Layfay-





The negative control scrambled siRNA (Dharmacon #
D-001810-10-05) consists of a pool of 4 sequences previ-
ously determined to have minimal effects on gene ex-
pression in mammalian cells [42]. Real-time PCR was
used to quantify the siRNA knockdown efficiency for
each transcript. cDNAs were made with SuperScript
VILO Mastermix (Invitrogen) containing the random
hexamer and OligodT primers. The relative quantity was
normalized with GAPDH and calculated using the ΔΔCt
method. The primers for real-time PCR were:
RBM45: fwd = 5′-CCTTATTCAAATTATGGT
CATGGAG
rev = 5′-GTGTTGCCATTTTTCTAAGGAGATCTG




GAPDH: fwd = 5′-GAAATCCCATCACCATCTTCCA
GG
rev = 5′-GAGCCCCAGCCTTCTCCATG
Subcellular fractionation and assessment of RBM45
solubility
HEK293 cells were grown in 10 cm tissue culture dishes
for fractionation into nuclear/cytoplasmic or total
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protein extracts. All extraction procedures were done at
4 °C in the presence of a protease inhibitor cocktail
(Sigma-Aldrich). Cytoplasmic extracts were obtained by
immersing cells in a hypotonic buffer (10 mM HEPES,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT) for 5 min
and then lysing cells by homogenization with a Dounce
homogenizer. The lysed cells were spun for 5 min at
1000 rpm to pellet nuclei and the supernatant was
retained as the cytoplasmic fraction and solubilized in
RIPA buffer. Cells were visualized by brightfield micros-
copy to confirm hypotonic buffer-induced swelling, cell
membrane lysis, and nuclear membrane integrity follow-
ing homogenization. The pelleted nuclei were washed,
re-suspended, centrifuged at 2800 g for 10 min, and
broken with sonication, which was also monitored by
brightfield microscopy. Following centrifugation at 2800
g for 10 min, the supernatant was retained as the nuclear
fraction and solubilized in RIPA buffer. The purity of
the lysate was determined by SDS-PAGE and Western
blotting for GAPDH and lamin A/C as cytoplasmic and
nuclear markers, respectively.
For assays examining RBM45 solubility under various
stressor conditions, HEK293 cells constitutively express-
ing FLAG-RBM45 (overexpressed or CRISPR-modified,
as described above) were grown on 10 cm plates until
confluent and were treated as indicated to induce the
formation of NSBs. The cells were harvested and frac-
tionated into soluble and insoluble protein fractions as
previously described [43] with minor modifications. Cells
from one 10 cm plate were harvested, lysed in 1.5 ml
RIPA buffer (150 mM NaCl, 1% NP-40, 0.1% SDS, 50
mM Tris, pH 8.0) at 4 °C for 15 min, sonicated, and cen-
trifuged at 100,000 g for 30 min at 4 °C. After centrifuga-
tion, the supernatant was collected as the RIPA-soluble
fraction and its protein concentration was determined
by BCA assay (Pierce). To prevent carryover of residual
soluble protein extract into the insoluble fraction, the
resulting pellets were washed once with RIPA buffer,
resonicated, recentrifuged at 100,000 g for 30 min at
4 °C, and the supernatant was removed. RIPA-insoluble
pellets were then extracted in 1.5 ml urea buffer (7M
urea, 2M thiourea, 4% CHAPS, 30 mM Tris, pH 8.5) at
room temperature for 20 min, sonicated, and centrifuged
at 100,000 g for 30 min at 22 °C. The final supernatant
was collected as the insoluble, detergent-resistant frac-
tion and its protein concentration was determined by
Bradford assay (Bio-Rad, Hercules, CA, USA). To inhibit
protein degradation, 1 mM PMSF (a protease inhibitor)
was added to all buffers prior to use.
SDS-PAGE and Western blotting
SDS-PAGE, total protein staining, and Western blotting
were performed as previously described [44]. In brief,
samples were mixed with LDS sample buffer
(Invitrogen), DTT reducing reagent, and deionized water
(as a diluent), heated at 70 °C for 10 min, and loaded
onto 1.5 mm 4–12% Bis-Tris gradient SDS-PAGE gels
(Invitrogen). For assays examining HSF1, SAFB, and
RBM45 abundance, 10 μg of protein was loaded from ly-
sates prepared as above. For assays examining the solu-
bility of RBM45, 15 μg of the RIPA-soluble fraction and
4 μg of the detergent-resistant fraction were loaded in
each lane. Gel runs were performed in 1X MOPS buffer
at a constant 200 V at 4 °C. Following SDS-PAGE, pro-
teins were transferred from gels to PVDF membranes.
Wet tank transfer was performed in Towbin buffer (25
mM Tris, 192 mM glycine) using a ramped transfer ap-
proach, as in Otter et al. [45], where samples were trans-
ferred for 6 h at a constant 8 V, then for a further 6 h at
16 V. Following the transfer, membranes were dried for
1 h, then rehydrated using methanol and deionized
water.
For Western blotting, membranes were initially
blocked in Odyssey blocking buffer (Licor) for 60 min.
Membranes were incubated in primary antibodies for 1–
12 h and washed three times for 15 min each in a
phosphate buffered saline (PBS) solution with Odyssey
blocking buffer added at a dilution of 1:10. Following the
washing step, membranes were incubated in solutions
containing secondary antibodies conjugated to IRDye
680 and IRDye 800 (LI-COR, Lincoln, NE, USA) for 60
min and washed as above. After secondary antibody in-
cubations membranes were washed 3 times for 15 min
each in Odyssey blocking buffer diluted 1:10 in PBS. Fi-
nally, immediately prior to imaging, membranes were
washed once in PBS to remove residual detergent from
the membrane. Blot images were acquired on an Odys-
sey CLx scanner (LI-COR) at 169 μm resolution at the
highest intensity setting at which no pixel saturation was
present in the resulting image.
Immunocytochemistry and Digital Deconvolution
Indirect immunofluorescence was performed as in Li
et al. [3] In brief, cells were grown on 20 mM #1.5 poly-
D-lysine (PDL)-coated coverslips. When cells reached
70% confluence, they were treated as indicated, washed
with 1X PBS, fixed in 4% paraformaldehyde for 10 min,
washed 3 times in PBS, and permeabilized for 10 min
using 0.1% Triton X-100 in PBS. Following additional
washing with 1X PBS to remove fixative and detergent,
cells were blocked with Superblock (Scytek, Logan, UT,
USA) for 1 h and immersed in primary antibody solu-
tions for 2 h. Subsequently, they were washed 4 times
(10 min each) with IF wash buffer (1:10 Superblock:1X
PBS), and immersed in secondary antibody solutions for
1 h. The secondary antibodies used were goat-anti-rabbit
Cy2 (Abcam, Cambridge, UK) and goat-anti-mouse Cy5
(Abcam). Following secondary antibody incubations,
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coverslips were washed 4 times as above, washed 4 times
with 1X PBS, incubated in a 300 nM DAPI solution for
10 min, and washed 4 times with 1X PBS. Coverslips
were immersed in increasing concentrations of 2,2′-thio-
diethanol (TDE) according to the method of Staudt et al.
[46], and mounted in a 97% TDE solution with a refract-
ive index of 1.518 to match that of the immersion oil
used for imaging.
Slides were imaged on an Observer Z1 (Zeiss, Jena,
Germany) microscope with a 1.4 NA 63x objective with
LED illumination. All images were acquired as three-
dimensional Z-stacks with a Z sampling depth of 12 μM,
X/Y sampling interval of 0.102 μM, and a Z sampling
interval of 0.240 μM. We performed shading correction
and background subtraction on all images prior to de-
convolution. Following image acquisition and initial pro-
cessing, images were deconvolved using Huygens digital
deconvolution software (SVI; RRID:SCR_014237). A
measured point spread function (PSF) was generated by
imaging 200 nm diameter fluorescent Tetraspeck beads
(a sub-resolution particle in this imaging system) (Life
Technologies, Waltham, MA, USA) mounted in 97%
TDE and inputting the obtained images into the Huy-
gens software’s PSF distiller application. The perform-
ance of the measured PSF was assessed by deconvolving
additional 10 μm image stacks of 200 nm fluorescent
beads using the measured and theoretical PSFs. Compar-
isons of the deconvolution result using the different
PSFs demonstrated that the measured PSF provided a
superior image restoration result compared to a theoret-
ical PSF, as assessed by the size and shape of the decon-
volved bead image. Alignment of individual channels in
the measured PSF was then used to correct images for
spherical aberration. All cell images were then decon-
volved using the measured PSF and a maximum likeli-
hood deconvolution algorithm.
Immunohistochemistry
Immunohistochemistry of lumbar spinal cord and hip-
pocampal brain tissue sections from non-neurological
disease control, sporadic ALS (sALS), c9ORF72 hexanu-
cleotide repeat expansion ALS (c9ORF72), and non-
c9ORF72 linked familial ALS (fALS), frontotemporal
lobar degeneration with TDP-43 proteinopathy (FTLD-
TDP), and Alzheimer’s disease (AD) subjects (all AD
subjects were Braak stage VI) was performed as previ-
ously described [1]. Tissue sections were obtained from
the Barrow Neurological Institute and Target ALS Mul-
ticenter post-mortem tissue bank cores. All participants
in the post mortem tissue bank cores provided IRB ap-
proved informed consent for the collection of post mor-
tem tissues. Subject demographics are shown in Table 1.
Formalin fixed, paraffin embedded tissue sections (6 μm
thick) were deparaffinized by immersion in xylene,
rehydrated by successive immersion in increasing con-
centrations of ultrapure water in ethanol, and subjected
to antigen retrieval. Antigen retrieval was performed in
citra buffer (pH 6.0; Biogenex, Fremont, CA, USA) by
steam heating for 30 min. Sections were washed in PBS,
blocked using Superblock (Scytek), and immersed in pri-
mary antibody solutions overnight. The next day, the
slides were washed 4 times in PBS and incubated in so-
lutions containing appropriate secondary antibodies con-
jugated to Alexafluor 488 and 594 for 1 h. Subsequently,
slides were again washed 4 times in PBS, and immersed
in a 300 nM DAPI solution for 10 min to stain cell nu-
clei. Following PBS washing, slides were immersed in a
Sudan black-based autofluorescence eliminator reagent
(Millipore) to quench endogenous lipofuscin autofluo-
rescence and mounted in gelvatol. All tissue immuno-
fluorescence images were acquired on a Zeiss LSM 720
confocal microscope. Images were acquired as three-
dimensional Z-stacks with a Z sampling range of 15 μm,
X/Y sampling interval of 0.102 μM, and a Z sampling
interval of 0.240 μm. Shading correction and background
subtraction were performed on all images.
Image analysis
Image analysis was performed using NIH ImageJ
(RRID:SCR_003070) [47]. We developed an image
analysis pipeline to (1) count the number of cells in
an image field, (2) count the number of RBM45 nu-
clear inclusions in each cell in an image field, and (3)
measure the nuclear fluorescence intensity in each
fluorescence channel in each cell in each image field.
These steps were carried out as follows. To count the
number of cells in each image, we created binary im-
ages of DAPI-stained nuclei using fixed intensity
thresholding. The ImageJ particle analyzer was then
used to count the number of DAPI-positive cells in
each image. Cell counts were further filtered by ex-
cluding possible false-positives on the basis of cell
size and shape. To count the number of RBM45 nu-
clear inclusions, we used the DAPI binary images as
an overlay mask to restrict analysis to RBM45 foci in
the nuclei of cells. These masked images were then
thresholded using the Robust Automatic Threshold
plugin [48]. The ImageJ particle analyzer was then
used to count the number of RBM45-positive foci in
the nucleus with particle sizes restricted to published
parameters for the size of nuclear stress bodies [33,
49]. Finally, the intensity of each fluorescence channel
in each cell nucleus in an image field was measured
using the corresponding DAPI binary image as an
overlay mask. We applied this image analysis pipeline
to cells from our immunocytochemistry experiments,
hippocampal dentate gyrus granule cells from ALS,
FTLD-TDP, AD, and non-neurological disease control
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tissue sections, and spinal cord motor neurons and
glia from ALS and non-neurological disease control
tissue sections. For each subject from our human
tissue analysis, a total of 8 fields per region (hippo-
campal dentate gyrus or lumbar spinal cord) were an-
alyzed. Each step in the image analysis pipeline was
Table 1 Subject demographics. Demographics for each case used for immunohistochemical analysis are shown. PMI = post mortem
interval (hours between death and tissue harvest); C9orf72 = presence or absence of C9orf72 hexanucleotide repeat expansion;
sALS = sporadic (i.e., non-familial) ALS; AD = Alzheimer’s disease, Braak stage VI; FTLD-TDP = frontotemporal lobar degeneration with
TDP-43 proteinopathy
Subject Group C9orf72 Age Sex PMI Hippocampus Spinal Cord
1 Control no 54 M 6 yes yes
2 Control no 53 F 4 yes yes
3 Control no 51 F 5 yes yes
4 Control no 76 M 13 yes yes
5 Control no 57 M 2 yes yes
6 Control no 48 M 2 yes yes
7 Control no 58 F 5 yes yes
8 Control no 76 M 14 yes no
9 Control no 82 F 5 yes yes
10 Control no 57 F 11 yes yes
11 sALS no 62 M 7 no yes
12 sALS no 50 F 7 no yes
13 sALS no 60 F 4 no yes
14 sALS no 59 M 4 yes yes
15 sALS no 77 F 4 yes yes
16 sALS no 79 F 4 yes yes
17 sALS no 52 F 21 yes yes
18 sALS no 45 M 7 yes no
19 sALS no 65 M 5 yes no
20 sALS no 66 M 18 yes yes
21 sALS no 53 F 12 yes yes
22 sALS no 73 F 6 no yes
23 sALS no 59 M 5 no yes
24 sALS no 48 F 5 no yes
25 ALS yes 68 M 4 no yes
26 ALS yes 43 M 6 no yes
27 ALS yes 63 F 4 no yes
28 AD no 71 M 4 yes no
29 AD no 84 F 5 yes no
30 AD no 85 M 5 yes no
31 AD no 73 F 4 yes no
32 AD no 71 F 5 yes no
33 FTLD-TDP no 69 M 6 yes no
34 FTLD-TDP no 67 M > 24 yes no
35 FTLD-TDP no 69 M 6 yes no
36 FTLD-TDP no 85 M 3 yes no
37 FTLD-TDP no 91 F 8 yes no
38 FTLD-TDP no 79 M 7 yes no
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evaluated by comparing its performance to manual
counts of at least 10 independent images, with a re-
quirement of 95% agreement between automated and
manual counts across images.
Antibodies
The following primary antibodies and dilutions were
used for all Western blotting experiments, rabbit poly-
clonal anti-C-terminal RBM45 (Pacific Immunology,
Fremont, CA, USA, custom, 1:2000), rabbit polyclonal
anti-N-terminal RBM45 (Pacific Immunology, custom, 1:
2000), rabbit polyclonal anti-RBM45 (Sigma-Aldrich, 1:
1000; RRID:AB_1856132), mouse-monoclonal anti-HA
(Sigma-Aldrich, 1:5000; RRID:AB_260092), mouse
monoclonal anti-FLAG M2 (Sigma-Aldrich F3165, 1:
5000; RRID:AB_259529), rabbit polyclonal anti-TDP-43
(Proteintech, Rosemont, IL, USA, 1:3000; RRID:AB_
2200505), mouse monoclonal anti-actin (Millipore, Bur-
lington, MA, USA, 1:5000; RRID:AB_2223041), rabbit
monoclonal anti-lamin A/C (Epitomics, San Francisco,
CA, USA, 1:1000; RRID:AB_10860619), and rabbit
monoclonal anti-GAPDH (Cell Signaling, Danvers, MA,
USA, 2118S, 1:5000; RRID:AB_561053). The following
secondary antibodies were used for Western blotting ex-
periments, each at a dilution of 1:10,000: goat anti-rabbit
IRDye 680 (LI-COR; RRID:AB_10956166), goat anti-
rabbit IRDye 800 (LI-COR; RRID:AB_621843), goat anti-
mouse IRDye 680 (LI-COR; RRID:AB_10956588), and
goat anti-mouse IRDye 800 (LI-COR; RRID:AB_621842).
The following primary antibodies and dilutions were
used for immunofluorescence and immunohistochemis-
try: rabbit polyclonal anti-RBM45 (Sigma-Aldrich, 1:75;
RRID:AB_1856133), rabbit polyclonal anti-RBM45 (cus-
tom; Pacific Immunology, 1:100), mouse monoclonal
anti- scaffold attachment factor B (SAFB, Lifespan Bio-
sciences, Seattle, WA, USA, 1:100; RRID:AB_2183072),
mouse monoclonal anti-SAFB (Proteintech, 1:100),
rabbit polyclonal anti-SAFB (Proteintech, 1:100), mouse-
anti-HSF1 (Abcam, 1:100), rabbit polyclonal anti-heat
shock factor 1 (HSF1; Proteintech, 1:100; RRID:AB_
10903615), mouse monoclonal anti-SC35 (Abcam, 1:300;
RRID:AB_298608), mouse monoclonal anti-coilin
(Abcam, 1:200; RRID:AB_476827), mouse monoclonal
anti-SMN (Sigma-Aldrich, 1:300; RRID:AB_477504),
mouse monoclonal anti-G3BP1 (Genentech, 1:100),
mouse monoclonal anti-TDP-43 (Proteintech, 1:100;
RRID:AB_2200520), mouse monoclonal anti-FUS
(Proteintech, 1:100; RRID:AB_10666169), and mouse
monoclonal anti-HA (Sigma-Aldrich, 1:1000; RRID:AB_
260092). Goat-anti-rabbit Cy2 (Abcam; RRID:AB_954992)
and goat-anti-mouse Cy5 (Abcam; RRID:AB_955063) sec-
ondary antibodies were used for immunofluorescence at a
dilution of 1:200. Goat-anti-rabbit Alexafluor 488 (Life
Technologoies; RRID:AB_2576217) and goat-anti-mouse
Alexafluor 594 (Life Technologies; RRID:AB_2534091)
secondary antibodies were used at a dilution of 1:200 for
human tissue immunohistochemistry experiments.
Data analysis
The statistical analysis of all data was performed using
Microsoft Excel (Microsoft, Redmond, WA, USA; RRID:
SCR_016137) and R (R Project for Statistical Computing;
RRDI:SCR_001905). Between groups comparisons were
performed using one-way analysis of variance (ANOVA)
with Tukey’s HSD post-hoc test. For the analysis of
RBM45 nuclear inclusions per cell in human tissues, we
used the non-parametric Mann-Whitney U test to per-
form all possible two group comparisons. The Bonfer-
roni correction was used to account for multiple testing
in these comparisons. Linear regression was used to
analyze the relationship between RBM45 nuclear inclu-
sion number and SAFB nuclear immunoreactivity. All
figures were constructed in Adobe Illustrator (Adobe,
Mountain View, CA, USA; RRID:SCR_010279) and
Inkscape (RRID:SCR_014479).
Results
RBM45 associates with nuclear stress bodies (NSBs)
To better understand the normal functions of RBM45
and the mechanisms leading to nuclear RBM45 inclusion
formation, we assessed RBM45’s co-localization with
markers of several membraneless organelles in HEK293
cells. We used established marker proteins for nuclear
speckles (SC35), Cajal bodies (coilin), nuclear gems
(SMN), cytoplasmic stress granules (SGs; G3BP), and
nuclear stress bodies (NSBs; SAFB and HSF1). As shown
in Fig. 1a-c, under basal conditions RBM45 is a predom-
inantly nuclear protein with minimal cytoplasmic immu-
noreactivity. Moreover, the protein is diffusely localized
throughout the nucleus and does not co-localize with
nuclear speckles, Cajal bodies, or nuclear gems.
We next examined whether cellular stress promotes
redistribution of RBM45 into stress-induced membrane-
less organelles. Sodium arsenite (0.5 mM for 1 h) led to
robust induction of G3BP-positive cytoplasmic stress
granules (Fig. 1d), however, cytoplasmic SGs did not
contain RBM45. Instead, sodium arsenite caused the dif-
fusely localized RBM45 to coalesce into nuclear puncta
(Fig. 1d). We then used heat shock (42 °C for 1 h) to in-
duce redistribution of SAFB and HSF1 into NSBs (Fig.
1e). As with sodium arsenite, we found that heat shock
led to the formation of nuclear RBM45 puncta and these
puncta co-localized with SAFB- and HSF1-positive NSBs
(Fig. 1e).
Because both sodium arsenite and heat shock led to
the formation of RBM45-positive NSBs, we asked
whether RBM45 incorporation into NSBs is a general re-
sponse to cellular stress. In addition to sodium arsenite
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and heat shock (Fig. 1e), we found that other NSB-
inducing stressors, including nutrient starvation (serum
deprivation, Fig. 2b), oxidative stress (400 μM H2O2, Fig.
2c), heavy metal stress (30 μM cadmium sulfate [CdSO4],
Fig. 2d), and genotoxic stress (20 μM mitoxantrone, Fig.
2e) led to the formation of RBM45-positive NSBs. As in
our initial experiments, under basal conditions, the dis-
tribution of RBM45 was diffuse and nuclear, with no
RBM45 puncta or NSBs visible (Fig. 2a). The stress con-
ditions used in these experiments also cause the forma-
tion of cytoplasmic SGs [35, 50–55]. Because previous
reports indicated that RBM45 associates with cytoplas-
mic SGs [4, 5], we also examined whether any of the
stressors tested led to the incorporation of RBM45 into
SGs. We found that all stressors led to the formation of
G3BP-positive SGs, but these did not contain RBM45
(Fig. S1).
NSBs are protein-RNA complexes that result from
stress-induced transcription of pericentromeric hetero-
chromatic satellite III (SatIII) repeats. SatIII transcripts
remain in close proximity to their genomic locus and act
as scaffolds for NSB assembly by recruiting various NSB
RNA binding proteins, including HSF1 and SAFB. NSBs
are proposed to result from a redistribution of existing
nuclear RBPs, rather than an increase in NSB protein
levels. To assess whether cellular stress alters RBM45
protein levels, we performed Western blotting for
RBM45 in HEK293 total protein extracts from un-
stressed HEK293 cells and cells subjected to oxidative or
genotoxic stress. Neither stressor increased RBM45,
HSF1, or SAFB protein levels in HEK293 cells (p > 0.05;
Fig. S2), consistent with existing models of NSB forma-
tion [31, 49, 56, 57].
We examined if RBM45-interacting proteins linked to
ALS are recruited to NSBs by virtue of their interactions
with RBM45. TDP-43 and FUS physically interact with
RBM45 [4], are predominantly nuclear proteins under
basal conditions, and have defined roles in the cellular
response to stress. We therefore assessed whether TDP-
43 or FUS can be incorporated into NSBs during cellular
stress. Heat shock did not lead to the incorporation of
Fig. 1 RBM45 association with membraneless nuclear organelles. a-c
HEK293 cells were immunostained for endogenous RBM45 and
marker proteins of the indicated organelles. Under basal conditions,
RBM45 is diffusely localized throughout the nucleus and does not
associate with nuclear speckles, Cajal bodies, or nuclear gems (a-c,
respectively). d Sodium arsenite (0.5 mM for 1 h) was used to induce
cytoplasmic stress granule formation. RBM45 does not associate with
G3BP1-positive cytoplasmic stress granules during cellular stress, but
coalesces into nuclear puncta. e Heat shock (42 °C for 1 h) led to a
redistribution of SAFB (top) and HSF1 (bottom) into nuclear stress
bodies (NSBs). Stress-induced RBM45 nuclear foci correspond to
NSBs, indicated by co-localization of RBM45 with the NSBs. For all
images, scale bar = 5 μm
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Fig. 2 RBM45 association with nuclear stress bodies is a general response to cellular stress. HEK293 cells were treated as indicated and the
distribution of RBM45 and SAFB-positive nuclear stress bodies (NSBs) was evaluated by immunocytochemistry. a In untreated cells, the
distribution of RBM45 and SAFB is diffuse and nuclear. b-e Treatment with the indicated stressors results in the formation of RBM45- and SAFB-
positive NSBs. For all images, scale bar = 5 μm
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either TDP-43 or FUS into RBM45-positive NSBs (Fig.
S3A). We overexpressed HA-tagged versions of full-
length TDP-43 and FUS and evaluated their effects on
NSB formation and their association with NSBs. As in
the preceding experiments, we did not observe associ-
ation of TDP-43 or FUS with NSBs (Fig. S3B). Overex-
pression of TDP-43, but not FUS, was sufficient to
promote NSB formation, consistent with previous stud-
ies showing that altered TDP-43 expression induces cel-
lular stress (Fig. S3B) [56, 57].
We also tested whether RBM45 is required for the for-
mation of NSBs using siRNA-based knockdown of
RBM45. qPCR experiments established that our RBM45
siRNAs effectively targeted RBM45, resulting in an ap-
proximately 70% decrease in transcript abundance (Fig.
S4). As a positive control for these experiments, we used
siRNAs targeting SatIII, as prior studies demonstrated
that SatIII knockdown abrogates NSB formation [40,
41]. SatIII siRNAs reduced transcript levels approxi-
mately 80% (Fig. S4). Neither the scrambled siRNA nor
knockdown of RBM45 prevented the formation of NSBs
(Fig. S5A, B, respectively). Consistent with previous find-
ings, knockdown of SatIII transcripts prevented NSB
formation and eliminated redistribution of RBM45,
SAFB, and HSF1 to nuclear foci during cellular stress
(Fig. S5C). Therefore, RBM45 associates with NSBs dur-
ing conditions of cellular stress, but is not essential for
NSB formation.
RNA binding domains are essential for RBM45 association
with NSBs
RBM45 is a 474 amino acid protein with 3 RNA recogni-
tion motifs (RRMs), a bipartite nuclear localization se-
quence (NLS), and a homo-oligomer assembly (HOA)
domain that mediates its self-association/oligomerization
and interaction with other proteins (Fig. 3a) [4, 6]. To
identify RBM45 domains required for association with
NSBs, we examined the co-localization of NSBs and
HA-tagged full-length RBM45, several domain deletion
mutant RBM45 constructs, and a nuclear localization
sequence (NLS)-disrupting RBM45 mutant construct
following heat shock. In unstressed cells, full-length HA-
tagged RBM45 exhibited a diffuse nuclear localization
and no HSF1-positive NSBs were observed (Fig. 3b). A
similar result was observed under basal conditions for all
RBM45 deletion constructs tested except the ΔNLS con-
struct, which was retained in the cytoplasm (Fig. S6).
Heat shock led to the incorporation of full-length, wild-
type RBM45 in HSF1-positive NSBs (Fig. 3c). Disruption
of the C-terminal bipartite NLS of RBM45 led to cyto-
plasmic sequestration of the protein and this was suffi-
cient to abrogate the association of RBM45 with NSBs
(Fig. 3d). Removal of the N-terminal RRM (RRM1) did
not alter the association of RBM45 and NSBs (Fig. 3e),
nor did removal of the protein’s HOA domain (Fig. 3h).
In contrast, removal of either RRM2 or RRM3 was suffi-
cient to prevent RBM45 from associating with NSBs
(Fig. 3f and g). Our data, therefore, suggests a direct
interaction of RBM45 with NSB SatIII transcripts via
RRM2 and RRM3, rather than by indirect association
with other NSB proteins.
Chronic stress promotes RBM45 nuclear aggregation
We next asked whether persistent association with NSBs
is sufficient to promote nuclear RBM45 inclusion forma-
tion. Nuclear RBM45 inclusions occur in ALS, FTLD,
and AD [1, 2] and cellular stress has previously been
shown to cause the formation of insoluble inclusions
containing other ALS/FTLD-linked RBPs such as TDP-
43 and FUS [20, 23, 24]. The formation of insoluble RBP
inclusions may result from the persistent association of
these proteins with cytoplasmic SGs. An analogous
process occurring via RBM45 association with NSBs
during chronic cellular stress could lead to the formation
of RBM45 nuclear inclusions. To understand the effects
of acute and chronic stress on the distribution and ag-
gregation of RBM45, we used a variety of cellular
stressors at differing concentrations and for varying du-
rations. Following acute and chronic stressor treatments,
we performed immunocytochemistry for endogenous
RBM45 and NSBs. As in prior experiments, under basal
conditions, RBM45 was diffusely localized throughout
the nucleus and no NSBs were visible (Fig. 4a). Acute
treatment with the genotoxic stressor MTX (5 μM for 6
h) led to the formation of RBM45-positive NSBs (Fig.
4b). To chronically stress cells with MTX, we tested a
range of MTX concentrations (0.5–5 μM), seeking to
find the maximum dose that did not adversely affect cel-
lular viability. Using a dose of 1 μM MTX for 24 h, we
found that chronic stress led to an increase in the size,
staining intensity, and number of RBM45 foci in the nu-
cleus of HEK293 cells, suggestive of the formation of
RBM45 inclusions (Fig. 4c). These inclusions were no
longer positive for NSB marker proteins. We used a
similar approach to compare the effects of acute and
chronic stress resulting from treatment with the cad-
mium sulfate (acute – 30 μM, 2 h; chronic – 5 μM, 24 h),
and sodium arsenite (acute – 1 mM, 1 h; chronic – 0.1
mM, 24 h). We found that acute stress lead to the for-
mation of SAFB/RBM45-positive NSBs (Fig. 4d, f). In
contrast, chronic stress led to the formation of large,
persistent RBM45-positive nuclear inclusions that were
negative for NSB marker proteins (Fig. 4e, g).
NSB formation leads to the concentration of NSB pro-
teins at sites containing SatIII transcripts, with attendant
depletion of these proteins from their normal cellular
milieu. Although acute cellular stress did not alter NSB
protein levels (Fig. S2), we observed that the
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redistribution of proteins to NSBs led to a decrease in
total nuclear NSB protein signal by quantitative im-
munocytochemistry (by changing from more diffuse to
distinct puncta staining). We used this approach to
quantify changes in RBM45 and SAFB immunoreactivity
during conditions of acute and chronic stress. To
visualize changes in RBM45 and SAFB on the same
scale, we converted the values for each protein to Z
scores. As expected, acute stress by MTX (5 μM for 6 h),
CdSO4 (30 μM for 2 h), and sodium arsenite (1 mM for1
hour) all significantly reduced the total nuclear RBM45
signal compared to untreated cells (p < 1 × 10− 11 for
MTX, p < 1 × 10− 9 for CDSO4, and p < 0.01 for sodium
arsenite; Fig. S7A). These acute stressors likewise signifi-
cantly reduced the total nuclear SAFB signal compared
to untreated cells (p < 1 × 10− 8 for MTX, p < 1 × 10− 9 for
CDSO4, and p < 1 × 10
− 12 for sodium arsenite; Fig. S7B).
By contrast, NSBs dissipated over the course of our
chronic stress conditions (1 μM MTX, 5 μM CdSO4, or
0.1 mM sodium arsenite for 24 h) (Fig. 4c, e, g). We
could detect this change as a significant increase in total
nuclear SAFB signal for two of our three chronic stress
conditions compared to the corresponding acute stressor
(p < 0.01 for acute MTX versus chronic MTX and acute
sodium arsenite, but p > 0.05 for acute versus chronic
CdSO4; Fig. S7B), as well as a non-significant difference
between untreated cells and these chronic stress condi-
tions (p > 0.05 for untreated versus chronic MTX and
sodium arsenite, but p < 1 × 10− 4 for untreated versus
chronic CdSO4; Fig. S7B). Chronic stress led to the for-
mation of nuclear RBM45 inclusions (Fig. 4c, e, g) and
we could detect this change as a significant decrease in
total nuclear RBM45 signal in cells in our chronic stress
conditions compared to untreated cells (p < 1 × 10− 9 for
untreated versus chronic MTX and p < 0.01 for un-
treated versus chronic CdSO4, and sodium arsenite; Fig.
S7A). We also observed that the total nuclear RBM45 sig-
nal did not differ between individual acute versus chronic
stress conditions, owing to RBM45’s confinement in NSBs
and nuclear inclusions, respectively (p > 0.05 for acute ver-
sus chronic MTX, acute versus chronic CdSO4, and acute
versus chronic sodium arsenite; Fig. S7A).
The RBM45 inclusions observed following chronic
stress may reflect a change in RBM45 solubility. Because
protein overexpression via transient transfection can
lead to the formation of protein inclusions independent
of cellular stress, we examined the solubility of endogen-
ous RBM45 at physiological expression levels. For these
experiments, we used CRISPR-Cas9 genome editing to
append a 3x FLAG tag to the N-terminus of the
endogenous RBM45 gene. We performed extensive
characterization of CRISPR-Cas9-edited RBM45
HEK293 cells lines and found a non-significant reduc-
tion in RBM45 expression at the RNA level via qPCR in
our CRISPR-RBM45 lines compared to unedited control
cell lines (p > 0.05; Fig. S8A). We also observed no ef-
fects on nuclear morphology (Fig. S8B), no differences in
RBM45 subcellular localization (Fig. S8B), or cellular
morphology (Fig. S8B), suggesting that our CRISPR-cas9
genome editing and expression of HA-tagged RBM45
did not interfere with cellular physiology or RBM45
function. Soluble and insoluble protein extracts were ob-
tained from FLAG-RBM45 cell lines as outlined in
Fig. 5a. The purity of the insoluble extract was deter-
mined by blotting for GAPDH, which is not a compo-
nent of the insoluble protein fraction in stressed or
unstressed cells. We used TDP-43, which increases in
the insoluble fraction following cellular stress, as a posi-
tive control [43]. As shown in Fig. 5b, heat shock or
treatment with sodium arsenite led to a significant in-
crease (p < 0.01 for both comparisons) in the amount of
insoluble RBM45 (denoted using anti-FLAG tag anti-
body). For treatment with sodium arsenite, we observed
that increasing the stress duration led to increased levels
of insoluble RBM45 (p < 0.05). Treatment with sodium
arsenite led to a concomitant decrease in the amount of
soluble RBM45 protein (p < 0.01), while heat shock did
not alter the levels of soluble RBM45 (p > 0.05). A simi-
lar pattern was observed for TDP-43, where sodium
arsenite stress significantly increased the amount of in-
soluble TDP-43 compared to unstressed cells (p < 0.01
for both comparisons), while heat shock increased the
amount of insoluble TDP-43 (p < 0.01), but did not alter
the amount of soluble TDP-43 (p > 0.05).
To understand the temporal dynamics of RBM45 NSB
association and inclusion formation, we used live-cell
imaging of HEK293 cells expressing N-terminally GFP-
tagged RBM45 under the control of the Tet repressor.
(See figure on previous page.)
Fig. 3 Domains required for RBM45 incorporation into nuclear stress bodies (NSBs). a Schematic showing functional domains and their position
in the full-length RBM45 protein. RRM = RNA recognition motif, HOA = homo-oligomer assembly domain, NLS = nuclear localization sequence.
HEK293 cells were transfected with constructs encoding N-terminally HA-tagged wild-type (WT) or domain-modified forms of RBM45 as indicated
to determine which domains of the protein are necessary for incorporation into NSBs. b In unstressed cells, the distribution of WT RBM45 is
diffuse and nuclear and no NSBs are observed. c Heat shock (42 °C for 2 h) leads to the robust formation of NSBs that are positive for wild-type
(WT) RBM45 and the NSB marker HSF1. d Removal of the RBM45 NLS (ΔNLS) leads to its sequestration in the cytoplasm and prevents its
association with NSBs during heat shock. e Removal of RRM1 (ΔRRM1) does not alter the association of RBM45 with NSBs. f Removal of RRM2
(ΔRRM2) prevents the association of RBM45 with NSBs. g Removal of RRM3 (ΔRRM3) prevents the association of RBM45 with NSBs. h Removal of
the RBM45 HOA domain (ΔHOA) does not alter the association of RBM45 with NSBs. For all images, scale bar = 5 μm
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Addition of 10 μg/ml doxycycline to the culture medium
led to robust expression of EGFP-RBM45. We used live-
cell imaging to measure the dynamics of RBM45 during
cellular stress. In untreated control cells, RBM45 main-
tained its diffuse nuclear localization for the 24 h dur-
ation of the live-cell imaging experiments (Fig. 6a). No
RBM45 nuclear inclusions were observed during this
period. In contrast, acute treatment with 0.5 mM sodium
arsenite led to the formation of RBM45-positive NSBs
(Fig. 6b). These foci emerged within 1 h of treatment
(arrowheads in Fig. 6b) and were almost completely
eliminated 5 h after removal of the stressor (Fig. 6b, T =
6 h panel). At the completion of the experiment, no
RBM45-positive NSBs were visible (Fig. 6b, T = 24 h
panel). In contrast, chronic treatment with 0.1 mM so-
dium arsenite for 12 h led to the formation of large nu-
clear RBM45 inclusions that persisted for the 24-h
duration of the experiment (Fig. 6c, T = 12 h and T = 24
h panels). These inclusions were larger, more numerous,
and brighter than those observed during acute stress
conditions (compare Fig. 6c T = 12 h panel to Fig. 6b
T = 3 h panel). The size and number of the RBM45 in-
clusions increased over time in chronic stress, unlike the
acute stress condition (Fig. 6c T = 6, 12, and 24 h
panels). The presence of multiple, large RBM45
inclusions also impacted nuclear morphology (Fig. 6c
panel T = 12 and T = 24 h).
Quantification of RBM45 NSB pathology in ALS, FTLD, and
AD subjects
To characterize cell-type specific patterns of RBM45
pathology in ALS, FTLD-TDP, and AD, we quantified
RBM45 nuclear and cytoplasmic pathology across these
diseases and measured the co-localization of the NSB
marker protein SAFB with RBM45 nuclear inclusions.
We first performed immunohistochemistry for RBM45,
SAFB, and TDP-43 in the dentate gyrus of non-
neurological disease controls, FTLD-TDP, ALS, and AD
(Fig. 7a-d). We focused our efforts on the dentate gyrus
as RBM45 nuclear inclusions are significantly more
prevalent in the dentate gyrus than in hippocampal pyr-
amidal neurons [1]. Subject demographics are shown in
Table 1. We used an image analysis pipeline to extract
the number of cells, the number of RBM45 nuclear
inclusions, and SAFB immunoreactivity by confocal mi-
croscopy (see Methods). Cytoplasmic RBM45 inclusions
were counted manually. We counted a total of 8 fields
per subject, corresponding to a total of 10,640 cells
across all groups. In non-neurologic disease controls,
RBM45 exhibited diffuse nuclear and strong
(See figure on previous page.)
Fig. 4 Chronic stress promotes RBM45 nuclear inclusion formation. HEK293 cells were treated with three separate cellular stressors for varying
durations to examine the effects of chronic and acute cellular stress on the subcellular distribution of RBM45 and nuclear stress body (NSB)
formation. a In untreated cells, the distribution of RBM45 is diffuse and nuclear and no SAFB-positive NSBs are visible. b Acute treatment (6 h)
with the genotoxic stressor mitoxantrone (MTX; 5 μM) induces the formation of RBM45- and SAFB-positive NSBs. c Chronic treatment with MTX
(24 h; 1 μM) leads to the formation of RBM45 inclusions via NSB formation. At 24 h, RBM45 nuclear inclusions are no longer positive for the NSB
marker SAFB. (d and e) Similar results were obtained with acute (d) and chronic (e) treatment of cells with the oxidative stressor cadmium sulfate
(CdSO4; 30 μM [acute] or 5 μM [chronic]) and the NSB marker SAFB. f and g Similar results were also obtained for acute and chronic treatment of
HEK293 cells with sodium arsenite (Ars; 1 mM [acute; g] or 0.1 mM [chronic; h]). For all images, scale bar = 5 μm
Fig. 5 RBM45 solubility during conditions of cellular stress. a Workflow to obtain soluble and insoluble total protein extracts from untreated and
stressed HEK293 cells expressing endogenous, N-terminally FLAG-tagged RBM45. “SN” = supernatant. b Western blotting for FLAG-tagged RBM45
(α-FLAG), GAPDH (negative insoluble fraction control), and TDP-43 (positive insoluble fraction control) following sodium arsenite treatment (1 mM
for 1 or 2 h). c FLAG-RBM45, GAPDH and TDP-43 solubility following heat shock (1 h at 42 °C)
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perinucleolar immunoreactivity in dentate gyrus granule
cells (Fig. 7a, arrowheads). These cells also exhibited
strong, diffuse nuclear SAFB immunoreactivity. In con-
trast, granule cells in FTLD-TDP, ALS, and AD patients
typically exhibited multiple RBM45 nuclear inclusions
with a corresponding loss of nuclear/perinucleolar
RBM45 immunoreactivity (Fig. 7b-d, respectively).
RBM45 nuclear inclusions were negative for SAFB, con-
sistent with our in vitro results in chronic stress condi-
tions. Cytoplasmic RBM45 inclusions were occasionally
observed in dentate gyrus granule cells and were positive
for TDP-43 (Fig. 7b-d, bottom panels [arrows]), but
negative for SAFB.
We quantified the number of nuclear and cytoplasmic
RBM45 inclusions in dentate gyrus granule cells of each
subject. The distribution of nuclear inclusions exhibited
a strong rightward skew, with many cells containing zero
inclusions. Accordingly, we used the non-parametric
Mann-Whitney U test to assess the differences in
RBM45 inclusion counts between groups. FTLD-TDP
subjects exhibited significantly more RBM45 inclusions
than non-neurologic disease controls, AD, or ALS sub-
jects (Fig. 7e; p < 1 × 10− 6 for control and AD and p <
0.01 for ALS versus FTLD-TDP, respectively). ALS sub-
jects had significantly more nuclear inclusions than con-
trol or AD subjects (p < 1 × 10− 6 and p < 0.01,
Fig. 6 Live-cell imaging of RBM45 nuclear stress body (NSB) and nuclear inclusion formation during conditions of cellular stress. HEK293 cells
induced to express N-terminal GFP-tagged RBM45 were used to visualize the subcellular distribution of RBM45 during normal conditions and
during acute and chronic cellular stress. a In untreated cells, RBM45 is predominantly nuclear and diffusely localized throughout the nucleus. b
Treatment with 0.5 mM sodium arsenite for 1 h causes the formation of numerous RBM45-positive nuclear stress bodies (NSBs; arrowheads). Cells
were treated with 0.5 mM sodium arsenite at t = 0 h. Under conditions of acute cellular stress, NSB formation is reversible, most RBM45-positive
NSBs have dissipated by t = 6 h, and RBM45 remains diffusely localized throughout the nucleus for the remainder of the experiment. c Chronic
cellular stress leads to the entrapment of RBM45 in nuclear inclusions. Cells were treated with 0.1 mM sodium arsenite for 12 h to assess the
effect of chronic cellular stress on RBM45 subcellular distribution. Because of the lower concentration of sodium arsenite, the time course of NSB
formation is altered. Following removal of sodium arsenite (panel “Washout”), RBM45 remains in nuclear inclusions for the remaining 12 h
duration of the experiment (arrowheads). For all panels, scale bar = 5 μm
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Fig. 7 RBM45 subcellular distribution and inclusion pathology in FTLD-TDP, ALS, and AD. Immunohistochemistry for RBM45, SAFB, and TDP-43
was performed in hippocampal dentate gyrus from non-neurologic disease control, FTLD-TDP, ALS, and AD subjects. a Control subjects showed
strong immunoreactivity for SAFB, TDP-43, and RBM45, with RBM45 immunoreactivity concentrated in the perinucleolar region (arrowheads) and
SAFB and TDP-43 diffusely localized throughout the nucleus. b RBM45 immunoreactivity was predominantly in nuclear inclusions in FTLD dentate
gryus cells, with attendant loss of cytoplasmic and perinucleolar immunoreactivity. Nuclear RBM45 inclusions lack SAFB and TDP-43. Dentate
gyrus cells containing RBM45 nuclear inclusions also exhibit reduced SAFB immunoreactivity. Several TDP-43 and RBM45-positive cytoplasmic
inclusions were found in FTLD subjects (arrow). c As in (b), but for ALS subjects. Nuclear RBM45 inclusions lack SAFB or TDP-43, and cytoplasmic
inclusions contain RBM45 and TDP-43 (arrow). d As in (b), but for AD subjects. Nuclear RBM45 inclusions lack SAFB and TDP-43, and cytoplasmic
inclusions contain RBM45 and TDP-43 (arrow). e Boxplot showing the number of RBM45 nuclear inclusions by group (# = p < 0.01, * = p < 1 ×
10− 6). f Stacked bar plot showing the number of RBM45 nuclear inclusions per cell by subject group. Most dentate gyrus cells from control
subjects have no inclusions, while FTLD-TDP, ALS, and AD subjects have significantly more granules per cell across the range of observed values.
g The relationship between RBM45 nuclear inclusions and SAFB immunoreactivity is shown, along with the regression line. Regardless of disease
state, with increasing numbers of RBM45 nuclear inclusions, SAFB immunoreactivity decreases, particularly at ≥3 granules per cell. The relationship
between these two variables is statistically significant (p < 1 × 10− 16). In the scatterplot shown, jitter is added to the points to more clearly
visualize the data, but the separation between inclusion integer numbers is still seen. The inset image shows an example of adjacent cells in an
FTLD-TDP subject where one cell with no RBM45 granules has strong SAFB nuclear immunoreactivity, while the neighboring cell has several
nuclear RBM45 inclusions and low SAFB nuclear immunoreactivity. In (a-d), the scale bar = 20 μm, while in the inset in (g) the scale bar = 5. For all
panels, FTLD = FTLD-TDP
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respectively). Because non-neurologic disease controls
had significantly more hippocampal dentate gyrus cells
than FTLD-TDP, ALS, or AD subjects, we repeated this
comparison after normalizing RBM45 inclusions to the
number of cells and found that FTLD-TDP had signifi-
cantly more nuclear inclusions per cell than ALS, AD,
and control subjects (p < 1 × 10− 6, p < 1 × 10− 8, respect-
ively). ALS subjects had significantly more RBM45 nu-
clear inclusions than control and AD subjects (p < 1 ×
10− 6 and p < 0.01, respectively). The comparison be-
tween AD and non-neurologic disease controls did not
reach statistical significance following multiple testing
correction (p = 0.015). We observed that cells containing
RBM45 nuclear inclusions often had multiple inclusions
(in some instances more than 10 per nucleus), irrespect-
ive of disease state (Fig. 7f). AD and ALS subjects
showed comparable proportions and numbers of inclu-
sions per cell, while the vast majority of cells from con-
trol subjects (> 85%) show 1 or fewer nuclear inclusions.
The proportion of hippocampal cells containing at least
1 nuclear RBM45 inclusion was significantly greater than
the proportion of cells containing at least 1 cytoplasmic
inclusion (p < 1 × 10− 8). Cytoplasmic RBM45 inclusions
were not observed in non-neurologic disease controls.
Summary statistics for RBM45 nuclear and cytoplasmic
pathology in the dentate gyrus are shown in Table 2.
In subjects with nuclear RBM45 inclusions, a bimodal
pattern of SAFB immunoreactivity was seen wherein
cells with multiple RBM45 nuclear inclusions had low
SAFB immunoreactivity and cells without RBM45 nu-
clear inclusions had higher SAFB immunoreactivity. We
quantified this relationship (Fig. 7g) and used linear re-
gression to assess its significance. Across all groups, in-
creasing numbers of RBM45 nuclear inclusions per cell
were associated with decreasing SAFB immunoreactivity
(p < 1 × 10− 16). SAFB nuclear immunoreactivity was
lowest when cells had ≥3 RBM45 nuclear inclusions
(Fig. 7g, inset).
We applied the same analysis to lumbar spinal cord
tissue sections from ALS and non-neurologic disease
controls. In motor neurons from non-neurologic disease
control subjects, RBM45 immunoreactivity was largely
nucleolar (Fig. 8a, arrowheads) and SAFB and TDP-43
immunoreactivity was diffuse. RBM45, TDP-43, or SAFB
nuclear and cytoplasmic inclusion pathology was absent
in control subjects (Fig. 8a). In contrast, ALS patients
frequently exhibited skein-like cytoplasmic RBM45 in-
clusion pathology that co-localized with TDP-43 but not
SAFB (Fig. 8b). We noted a decrease in RBM45 nucle-
olar immunoreactivity in spinal cord motor neurons
containing cytoplasmic RBM45 inclusions (Fig. 8b, ar-
rowheads). Despite altered RBM45 motor neuron nucle-
olar immunoreactivity, we did not detect nuclear
RBM45 inclusions in motor neurons of ALS subjects
(Fig. 8b, Table 2). Instead, we frequently observed
RBM45 nuclear inclusions in adjacent glial cells in ALS,
but not in non-neurologic disease controls (Fig. 8b and
c [arrows]; Table 2).
We quantified lumbar spinal cord glial cells and glial
nuclear RBM45 inclusions in individual image fields. A
total of 3382 lumbar spinal cord glial cells across 26 sub-
jects were counted using this approach. Glial cells in
Table 2 Summary statistics from tissue immunohistochemistry image analysis. The table shows the number of individuals and
cells counted for each tissue region and subject group. The number of neurons or glial cells and RBM45 nuclear and
cytoplasmic inclusions were counted as described in the Methods section. For each subject, a total of 8 fields per region
















Dentate Gyrus Granule Cells
Control 10 4145 51.81 4.92 0.44 0.09 0 0
AD 5 1590 39.75 8.32 0.98 0.34 0.044 0.051
ALS 8 2943 45.98 5.98 1.49 0.27 0.048 0.055
FTLD-TDP 6 1962 40.92 5.81 2.38 0.23 0.109 0.072
Spinal Cord Glial Cells
Control 9 693 9.62 1.18 0.23 0.06 0 0
ALS 15 2689 22.35 1.74 1.04 0.18 0.11 0.47
Spinal Cord Motor Neurons
Control 9 308 4.29 0.53 0 0 0 0
ALS 15 351 2.91 0.42 0 0 0.15 0.14
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Fig. 8 RBM45 subcellular distribution and inclusion pathology in lumbar spinal cord. Immunohistochemistry for RBM45 with either SAFB or TDP-
43 was performed in lumbar spinal cord sections from ALS and non-neurologic disease control subjects. a RBM45, SAFB, and TDP-43
immunoreactivity were measured in motor neurons and glial cells of non-neurologic disease control subjects. RBM45 exhibited strong nucleolar
immunoreactivity in motor neurons (arrowheads), while SAFB and TDP-43 immunoreactivity were diffusely nuclear. b In ALS patients, motor
neuron nucleolar RBM45 immunoreactivity was reduced (arrowheads) and large, skein-like cytoplasmic inclusions were observed. These inclusions
were positive for TDP-43 but negative for SAFB. ALS patient glial cells frequently contained multiple RBM45 nuclear inclusions (arrows). c Glial
cells from non-neurologic disease control (top) and ALS (bottom) subjects. Glial cells from ALS subjects frequently contained 1 or more nuclear
RBM45 inclusions. The presence of glial RBM45 nuclear inclusions was associated with reduced SAFB immunoreactivity. d Boxplot showing the
number of glial nuclear RBM45 inclusions in control and ALS subjects. For the comparison shown, * = p < 1 × 10− 8. e Stacked bar plot showing
the proportion of cells (Y axis) with the given number glial nuclear RBM45 inclusions (X axis) across groups. ALS subjects have significantly more
inclusions per glial cell than control subjects, who rarely exhibit RBM45 glial cell pathology. f The relationship between glial RBM45 nuclear
inclusions and SAFB immunoreactivity is shown, along with the regression line. Increasing numbers of RBM45 nuclear inclusions are associated
with reduced SAFB immunoreactivity, particularly at ≥3 granules per cell. The relationship between these two variables is statistically significant
(p < 1 × 10−6). In the scatterplot shown, jitter is added to the points to more clearly visualize the data, but the separation between inclusion
integer numbers can still be seen. The inset image shows an example of adjacent glial cells in an ALS patient where one cell without RBM45
nuclear inclusions has strong SAFB nuclear immunoreactivity, while the neighboring cell with RBM45 nuclear inclusions shows reduced SAFB
immunoreactivity. In (a and b) the scale bar = 20 μm, in (c) the scale bar = 5 μm, and for the inset in (f) the scale bar = 2.5 μm
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ALS patients contained significantly more RBM45 nu-
clear inclusions per cell than those from non-neurologic
disease controls (Fig. 8d, p < 1 × 10− 8). While approxi-
mately 90% of glial cells in control spinal cord exhibited
no RBM45 nuclear inclusions, greater than 50% of ALS
glial cells had one or more RBM45 nuclear inclusions
(Fig. 8e). The proportion of spinal cord glial cells con-
taining nuclear RBM45 inclusions was significantly
greater than the proportion of spinal cord glial cells with
cytoplasmic RBM45 inclusions (p < 1 × 10− 4; Table 2).
Similar to the hippocampus, glial cells that contained
multiple RBM45 nuclear inclusions displayed reduced
SAFB immunoreactivity (Fig. 8f, inset). We explored the
relationship between nuclear RBM45 inclusion number
and SAFB immunoreactivity and found that greater
numbers of RBM45 inclusions per cell were associated
with decreasing SAFB nuclear immunoreactivity (Fig. 8f,
p < 1 × 10− 6). SAFB nuclear immunoreactivity was low-
est when cells had ≥3 RBM45 nuclear inclusions (Fig. 8f,
inset). Summary statistics for the image analysis of hu-
man spinal cord tissue are shown in Table 2.
Discussion
The goals of this study were to further characterize the
normal functions of RBM45, define the mechanisms by
which RBM45 forms nuclear inclusions, and quantify
cell type-specific patterns of RBM45 inclusion pathology
in FTLD-TDP, ALS, and AD. We found that RBM45
associates with nuclear stress bodies (NSBs), stress-
induced protein-RNA complexes, in response to a di-
verse array of cellular stressors as part of its normal
functions. This association is mediated by the protein’s
nuclear localization sequence and RNA recognition mo-
tifs (RRM) 2 and 3. In addition, the chronic entrapment
of RBM45 in NSBs was sufficient to promote nuclear
RBM45 inclusion formation, even when other NSB pro-
teins had disassociated from these complexes. In human
CNS tissue, nuclear RBM45 inclusions were frequently
found in ALS, FTLD-TDP, and AD in distinct cell types
and this pathology occurs more frequently than cyto-
plasmic RBM45 inclusions. Nuclear RBM45 inclusions
in post-mortem tissue lack NSB marker proteins, con-
sistent with our in vitro models of chronic stress.
Aggregation and assembly into membraneless organ-
elles is essential to the normal functions of many RBPs,
and aids in regulating transcription, mRNA splicing,
transport, and decay [58]. The assembly of RBPs, nucleic
acids, and other factors into membraneless organelles
acts to compartmentalize these components, leading to a
high local concentration of enzymes and substrates of
the associated biochemical reactions [58–60]. Our prior
work demonstrated that RBM45 regulates mRNA pro-
cessing and forms oligomeric complexes and interacts
with other RBPs via an intrinsically disordered region
termed the homo-oligomer assembly (HOA) domain [3,
4]. We, therefore, sought to determine whether RBM45
associates with an RBP-containing nuclear organelle. To
this end, we examined the co-localization of RBM45 and
several membraneless, RBP-containing organelles, in-
cluding nuclear speckles, Cajal bodies, nuclear gems, and
NSBs. Under basal conditions RBM45 does not co-
localize with any of these organelles and, instead, ex-
hibits a diffuse nuclear localization (Fig. 1). Subse-
quently, we observed that RBM45 coalesces into nuclear
puncta following the onset of cellular stress and these
puncta correspond to NSBs (Figs. 1 and 2).
NSBs are protein-RNA complexes that form in re-
sponse to stress-induced transcription of satellite III
(SatIII) repeats from pericentromeric heterochromatin
[49]. The resultant SatIII transcripts act as scaffolds that
recruit various RBPs to NSBs, notably the transcription
factor HSF1 and the hnRNP SAFB, resulting in the ap-
pearance of several nuclear granules that disassemble
following stressor removal [40, 49]. Despite a well-
characterized mechanism of formation, the functions of
NSBs have remained enigmatic. Current theory suggests
that NSBs act as one component of a larger gene expres-
sion regulatory program in the cellular response to stress
[49]. By sequestering various DNA/RNA binding pro-
teins, such as RBM45, SAFB, and HSF1, NSBs are
thought to alter gene expression through effects on both
transcription and splicing. Aside from this general
model, however, little is known about how NSBs alter
the function of their constituent proteins during stress.
NSBs are specific to primate cells and are not found in
other organisms, including rodents [40, 49]. Conse-
quently, the role of NSB proteins in the cellular response
to stress may exhibit species-specific differences. Further
studies are needed to understand the role of NSBs in the
cellular response to stress and how incorporation into
NSBs alters the gene regulatory functions of RBM45 and
other NSB proteins.
RBPs can be recruited to NSBs by direct binding to
SatIII transcripts or indirectly via protein-protein inter-
actions with resident NSB proteins [49]. Our data indi-
cates that recruitment of RBM45 to NSBs requires RNA
binding motifs (RRM2 or RRM3) and does not require
the HOA domain that mediates protein-protein interac-
tions with other RBPs (Fig. 3). This suggests that RBM45
associates with NSBs via direct RNA binding. Prior stud-
ies demonstrated that RBM45 has a binding preference
for poly (C) and poly (G) RNA [6]. The SatIII transcripts
that act as the scaffolds for NSBs are themselves G- and
C-rich [40, 41], consistent with our hypothesis that
RBM45 incorporation into NSBs is a consequence of dir-
ect binding to SatIII transcripts. We observed that
RBM45 is not required for the formation of NSBs (Fig.
S5). This result is not unexpected given that the
Collins et al. Acta Neuropathologica Communications            (2020) 8:91 Page 20 of 25
mechanism of NSB formation is transcription of SatIII
DNA by HSF1 binding rapidly following stress onset [40,
49]. NSB formation also exhibits cell- and stressor-
specific variability and even HSF1 itself is dispensable
for NSB formation during certain types of cellular stress
[32]. Thus, the primary function of RBM45 in NSBs ap-
pears to be removing the protein from its normal, diffuse
nuclear localization, similar to other NSB proteins [49].
Previous studies reported that RBM45 associates with
cytoplasmic stress granules and interacts with stress
granule proteins, notably TDP-43 and FUS [4, 5]. We
examined the distribution of RBM45 during conditions
of cellular stress and found no evidence of RBM45 cyto-
plasmic translocation or association with cytoplasmic
SGs (Fig. 1d, e and Fig. S1). Several factors may account
for the conflicting claims regarding RBM45 and SGs
made here and elsewhere. First, previous reports of
RBM45 association with SGs were made using plasmid-
based overexpression of RBM45 with a mutated, non-
functional NLS [4, 5]. While such approaches establish
that RBM45 can associate with SGs, they rely on artifi-
cially disrupting the normal subcellular localization of
RBM45 and expressing the protein at non-physiological
levels. Our study using wild-type RBM45 expression at
physiologic levels failed to identify RBM45 association
with cytoplasmic SGs under a diverse array of stress
conditions (Fig. S1). Consistent with this observation, re-
cent studies to comprehensively characterize the SG
proteome failed to detect RBM45 within SGs [55, 61].
After identifying RBM45 as a component of NSBs, we
asked whether chronic entrapment of the protein in
these structures could seed nuclear RBM45 inclusion
formation. RBM45 self-assembles into higher-order olig-
omers [4] and this behavior is likely essential to one or
more of the protein’s normal functions, similar to other
aggregation-prone RBPs [55, 62]. While acute stress re-
sults in transient RBM45 association with NSBs, chronic
stress was sufficient to convert RBM45 into an insoluble
form and irreversibly trap the protein in nuclear inclu-
sions (Figs. 4, 5 and 6). Importantly, in the absence of
SatIII transcripts, this phenomenon was not observed
(Fig. S5), indicating that RBM45 nuclear aggregation and
inclusion formation requires the initial formation of
RBM45 containing NSBs. We also observed that TDP-43
and FUS are not recruited to NSBs (Fig. S3). This result
suggests these proteins are not components of the nu-
clear RBM45 inclusions we observe in FTLD-TDP, ALS,
and AD because they are not recruited to NSBs.
RBM45 nuclear inclusions that result from chronic
stress lack NSB marker proteins, despite initial co-
localization in NSBs (Fig. 4). Similarly, we did not ob-
serve co-localization of RBM45 and NSB marker pro-
teins in ALS, FTLD, or AD tissue (Figs. 7 and 8). Several
factors may account for these observations. The HOA
domain that mediates RBM45 self-association is an in-
trinsically disordered peptide segment that promotes the
assembly of RBM45 oligomers [4]. Chronic stress likely
facilitates this process via compartmentalization in NSBs
in a manner analogous to the sequestration and aggrega-
tion of TDP-43 and FUS in cytoplasmic SGs. HSF1 and
SAFB do not oligomerize into large, macromolecular as-
semblies as part of their normal functions. HSF1 func-
tions as a DNA binding-competent trimer and is only
detectable in NSBs over a limited time course, specific-
ally the early, but not late, phase of NSB lifetime [50].
SAFB likewise functions as a monomer or homodimer,
but has not previously been shown to assemble into olig-
omeric complexes. It too, is detected over a limited time
frame in the lifespan of a NSB, appearing approximately
1 h after HSF1 granules are detectable [50]. Despite the
fact that RBM45, HSF1, and SAFB are all incorporated
into NSBs, no direct physical interaction between these
proteins has previously been observed [3]. The physical
and temporal separation of these proteins, together with
the low aggregation potential of HSF1 and SAFB, pro-
vide plausible explanations for the absence of these pro-
teins in RBM45 nuclear inclusions resulting from
chronic stress. RBM45 nuclear inclusions may nonethe-
less contain additional proteins and future studies will
characterize the proteome of these structures.
A consistent finding from our in vitro and human tis-
sue data is that nuclear RBM45 inclusions abrogate the
normally diffuse localization of RBM45 protein in the
nucleus (Figs. 4, 7, 8, S7). These results raise the possi-
bility that RBM45 inclusions lead to loss of the normal
functions of RBM45 by sequestering the protein from its
normal sites of activity. RBM45 inclusions could, thus,
contribute to cell death in disease via a “two-hit” model,
wherein inclusions cause both toxic gain and loss of
function. Such a model is well-established for other
aggregation-prone RBPs in disease, including TDP-43
and FUS [21, 63, 64]. RBM45 regulates mRNA splicing
and processing [3, 65] and perturbing these functions
may, therefore, have broad effects on gene expression
and cellular physiology. Studies of RBM45’s role in sev-
eral biological processes support this prediction, showing
that RBM45 regulates mitochondrial function [5], lipid
metabolism [65], and the immune response [66]. How-
ever, further studies into the RNA targets of RBM45 are
needed to more precisely predict how loss of the pro-
tein’s normal functions influences gene expression and
other cellular and organismal phenotypes.
RBM45 is frequently observed in cytoplasmic and nu-
clear inclusions in neurons and glia in FTLD-TDP, ALS,
and AD, but not in non-neurologic disease controls [1,
2]. To better understand cell type- and disease-specific
patterns of RBM45 inclusion pathology in neurodegener-
ative diseases, we performed an extensive quantification
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of RBM45 pathology in ALS, FTLD-TDP, AD, and non-
neurologic disease controls. In the hippocampal dentate
gyrus, numerous RBM45 nuclear inclusions with a punc-
tate morphology were observed in FTLD, AD, and ALS
subjects, but not in non-neurologic disease controls.
When we quantified the number of cells and RBM45 nu-
clear inclusions in each cell, we found that FTLD sub-
jects had the highest proportion of cells with at least 1
nuclear inclusion and the highest average number of nu-
clear inclusions per cell. RBM45 nuclear inclusions were
negative for TDP-43 or SAFB. Instead, we found that
the presence of RBM45 nuclear inclusions correlated
with disruption of the normal distribution and immuno-
reactivity of SAFB in ALS, FTLD, and AD (Figs. 7 and
8), similar to our results with chronic CdSO4 treatment
(Fig. S7). Critically, this was not due to a general de-
crease in SAFB immunoreactivity, as neighboring cells
without RBM45 nuclear inclusions showed strong SAFB
immunoreactivity comparable to non-neurologic disease
controls (Figs. 7g and Figs. 8f, inset). The distribution of
RBM45 nuclear inclusions in dentate gyrus granule cells
ranged from 0 to 17, with the majority of cells harboring
> 5 inclusions found in FTLD subjects. This range of
values shows good agreement with previous efforts to
quantify the number of NSBs that form in response to
different stressors in cultured cells. One study found that
individual HeLa cells typically produced 1–20 NSBs in
response to a variety of stressors, with 50% of cells har-
boring 1–5 NSBs [32]. We hypothesize that RBM45 nu-
clear inclusions in human post-mortem tissues denote
the prior generation of NSBs in these cells with subse-
quent chronic stress. We observed RBM45 nuclear in-
clusions in some aged non-neurologic disease controls,
though this may be due to the normal aging process as
seen with other RBPs [67, 68].
We also quantified RBM45 pathology in the lumbar
spinal cord of ALS and non-neurologic disease controls.
As in our prior study, we found TDP-43-positive
RBM45 cytoplasmic inclusions in motor neurons of ALS
but not non-neurologic control subjects (Fig. 8). A key
finding from this study is RBM45 nuclear inclusions
show cell-type specificity in ALS spinal cord. Specifically,
we observed RBM45 nuclear inclusions in ALS glial
cells, but not motor neurons. RBM45 exhibits a predom-
inantly nucleolar immunoreactivity in motor neurons in
human CNS tissue that was not seen in any other cell
type examined (Fig. 8). We hypothesize that the RBM45
nucleolar localization in motor neurons limits the pro-
tein’s ability to associate with NSBs, and hence, generate
nuclear inclusions. Alternatively, spinal cord motor neu-
rons may not form NSBs upon cellular stress. We ob-
served that cytoplasmic sequestration of RBM45 in
inclusions is associated with reduced nucleolar RBM45
immunoreactivity (Fig. 8). In contrast to motor neurons,
glial cells in the lumbar spinal cord of ALS subjects fre-
quently had RBM45 nuclear inclusions (Fig. 8). Notably,
the proportion of glial cells with at least one RBM45 nu-
clear inclusion was significantly greater than the propor-
tion of glial cells with cytoplasmic RBM45 inclusions
(Fig. 8 and Table 2). Similar to our in vitro results and
those from the dentate gyrus, we also found that glial
SAFB immunoreactivity was reduced in the presence of
RBM45 nuclear inclusions. Glial inclusion pathology oc-
curs in various forms of ALS and glial inclusions may
contain TDP-43, FUS, SOD1, C9ORF72-associated di-
peptide repeat proteins (DPRs), or other ALS-associated
proteins [69, 70]. The occurrence of RBM45 inclusions
in both the cytoplasm and nucleus of ALS glial cells, to-
gether with the diversity of other proteins found in glial
inclusions in ALS, underscores the predominant role of
glial dysfunction in the pathobiology of ALS and related
diseases.
Overall, our results demonstrate that RBM45 associ-
ates with NSBs during cellular stress and that chronic
stress leads to persistent self-association of RBM45 and
nuclear RBM45 inclusion formation. Nuclear RBM45 in-
clusions are extensively found in the hippocampal den-
tate gyrus in ALS, FTLD, and AD, as well as in glial cells
in ALS spinal cord. The presence of nuclear inclusions is
associated with depletion of RBM45 from its normal
subcellular milieu and altered distribution of other RBPs.
Collectively, our results provide new insights into the
biological functions of RBM45, the mechanisms by
which RBM45 forms inclusions, and implicate NSBs in
the pathogenesis of several neurodegenerative diseases.
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Additional file 1: Figure S1. Assessment of RBM45 association with
cytoplasmic stress granules (SGs). HEK293 cells were stained for RBM45
and the SG marker protein G3BP. (a) In untreated cells, the distribution of
RBM45 is diffuse and nuclear, while the distribution of G3BP is diffuse
and cytoplasmic. (b-g) Treatment with the indicated stressors induced
the robust formation of G3BP-positive SGs, which were negative for
RBM45. RBM45-positive nuclear stress bodies form in response to each
stressor. Arsenite = 1 mM arsenite for 1 h, Heat Shock = 42 °C for 1 h,
Serum Dep = serum deprivation for 2 h, CdSO4 = 30 μM cadmium sulfate
for 2 h, MTX = 20 μM mitoxantrone for 6 h.
Additional file 2: Figure S2. Nuclear stress body (NSB) protein levels
during conditions of cellular stress. Total protein extracts were prepared
from untreated cells, heat shocked cells (42 °C for 2 h), and cells treated
with the genotoxic stressor mitoxantrone (MTX; 20 μM for 6 h). Each
panel shows the results of loading 10 μg of each extract and blotting for
the indicated proteins with actin used as a loading control. (a) RBM45; (b)
heat shock factor 1 (HSF1); (c) scaffold attachment factor B (SAFB). No
statistically significant differences in the levels of RBM45, HSF1, or SAFB
were detected between treatment conditions (p > 0.05).
Additional file 3: Figure S3. Assessment of TDP-43 and FUS association
with nuclear stress bodies (NSBs). (a) HEK293 cells were heat-shocked for
2 h at 42 °C to induce formation of NSBs. Cells were stained for endoge-
neous RBM45 and TDP-43 or FUS as indicated. Following heat shock,
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numerous RBM45-positive NSBs become visible in the cell nucleus (ar-
rows) and these do not contain TDP-43 or FUS. Some TDP-43-positive
stress granules are visible in the cytoplasm following heat shock and
these do not contain RBM45. (b) HEK293 cells were transiently transfected
to overexpress HA-tagged TDP-43 or FUS and were then stained for the
HA tag and the NSB marker HSF1. Overexpression of TDP-43 was suffi-
cient to induce NSB formation, but NSBs were negative for TDP-43. Nei-
ther overexpression of FUS or transfection with a control HA vector
resulted in NSB formation. For all images, scale bar = 10 μm.
Additional file 4: Figure S4. siRNA targeting of RBM45 and SatIII.
HEK293 cells were transfected with the indicated siRNA and transcript
levels were measured by real-time PCR. Each bar presents the relative
transcript abundance, expressed as a proportion of the corresponding
transcript level in untreated cells transfected with a scrambled control
siRNA. (a) Evaluation of two unique siRNAs, each targeting RBM45. (b)
Evaluation of satellite III (SatIII) knockdown efficiency in untreated and
heat shocked (42 °C for 2 h) cells.
Additional file 5: Figure S5. Nuclear stress body (NSB) formation
during RBM45 and SatIII knockdown. HEK293 cells were transfected with
siRNAs targeting RBM45, SatIII, or off-target scrambled siRNAs (control).
NSB formation was then assessed by immunocytochemistry following
treatment with 1 mM sodium arsenite for 1 h. (a) Effect of off-target,
scrambled siRNA (control) on NSB formation. Cells transfected with con-
trol siRNAs readily form SAFB, RBM45, and HSF1-positive NSBs following
treatment with sodium arsenite. (b) Cells transfected with siRNAs target-
ing RBM45 show reduced levels of RBM45, but readily form SAFB and
HSF1-positive NSBs following cellular stress. (c) Knockdown of SatIII leads
to a loss of NSB formation during cellular stress as indicated by the loss
of SAFB, RBM45, and HSF1-positive NSBs in cells transfected with SatIII tar-
geting siRNAs. For all images, scale bar = 5 μm.
Additional file 6: Figure S6. Subcellular localization of full-length, do-
main deletion, and mutant NLS RBM45 constructs in untreated cells. (a)
Schematic showing functional domains and their position in the full-
length RBM45 protein. RRM = RNA recognition motif, HOA = homo-
oligomerization domain, NLS = nuclear localization sequence. HEK293
cells were transfected with constructs encoding N-terminally HA-tagged
wild-type (WT) or domain-modified forms of RBM45 as indicated. (b) In
untreated cells, the distribution of WT RBM45 is diffuse and nuclear. (c)
Removal of the RBM45 NLS (ΔNLS) leads to cytoplasmic sequestration of
RBM45. (d-g) Removal of RRM1 (ΔRRM1; d), RRM2 (ΔRRM2; e), RRM3
(ΔRRM3; f) and the HOA domain (ΔHOA; g) do not alter the diffuse, nu-
clear localization of RBM45. No HSF1-positive NSBs are observed in un-
treated cells expressing any of the indicated RBM45 constructs. For all
images, scale bar = 5 μm.
Additional file 7: Figure S7. Quantitative immunocytochemical analysis
of RBM45 and SAFB during acute and chronic stress conditions. Nuclear
RBM45 and SAFB were quantified by immunocytochemistry and image
analysis in untreated and acute and chronically stressed HEK293 cells. To
compare RBM45 and SAFB on the same scale, each protein’s signal was
converted to Z scores. (a) Nuclear RBM45 levels in untreated and stressed
cells. The genotoxic stressor mitoxantrone (MTX, acute = 6 h, 5 μM;
chronic = 24 h, 1 μM), the heavy metal stressor cadmium sulfate (CdSO4,
acute = 2 h, 30 μM; chronic = 24 h, 5 μM), and the oxidative stressor
sodium arsenite (Ars, acute = 1 h, 1 mM; chronic = 24 h, 0.1 mM) all
significantly reduced the nuclear RBM45 signal compared to untreated
cells. (b) Acute MTX treatment, but not chronic MTX treatment
significantly reduced the nuclear SAFB signal compared to untreated
cells. Acute and chronic CdSO4 treatment significantly reduced the
nuclear SAFB signal compared to untreated cells. Acute sodium arsenite
treatment, but not chronic sodium arsentie treatment significantly
reduced the nuclear SAFB signal compared to untreated cells. For (a) and
(b), * = p < 1 × 10− 5, # = p < 0.01.
Additional file 8: Figure S8. Characterization of endogeneous RBM45
CRISPR-cas9 edited HEK293 cells. CRISPR-cas9 genome editing was used
to generate HEK293 cells expressing N-terminally 2x FLAG-tagged RBM45.
(a) RBM45 transcript levels were evaluated by real-time PCR. The barplot
presents the mean RBM45 transcript levels relative to unedited cells ex-
pressing wild-type RBM45. (b) Immunofluorescence was performed using
an antibody to RBM45 in CRISPR-edited HEK293 cells. The results show
that the abundance and subcellular distribution of RBM45 protein and
HEK293 cell nuclear morphology are not altered by the 2X FLAG tag.
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